These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36926664)

  • 1. COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.
    Said ZNA; El Habashy SA; Zaky S;
    World J Gastroenterol; 2023 Feb; 29(7):1123-1130. PubMed ID: 36926664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver injury in severe COVID-19 infection: current insights and challenges.
    Ali N; Hossain K
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):879-884. PubMed ID: 32649840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and liver disease: mechanistic and clinical perspectives.
    Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of COVID-19 on Liver Injury.
    Dawood DRM; Salum GM; El-Meguid MA
    Am J Med Sci; 2022 Feb; 363(2):94-103. PubMed ID: 34752738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis.
    Zhao X; Lei Z; Gao F; Xie Q; Jang K; Gong J
    Medicine (Baltimore); 2021 Jan; 100(4):e24369. PubMed ID: 33530232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments.
    Zhao SW; Li YM; Li YL; Su C
    World J Gastroenterol; 2023 Jan; 29(2):241-256. PubMed ID: 36687127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and the liver: A 2021 update.
    Spearman CW; Aghemo A; Valenti L; Sonderup MW
    Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic.
    Farshidpour M; Kim D; Junna S; Merchant J
    Indian J Gastroenterol; 2020 Jun; 39(3):232-235. PubMed ID: 32621206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Injury in COVID-19: A Direct Hit or Collateral Damage?
    Vairappan B; Wright G; Corrigal D; Ts R
    Infect Disord Drug Targets; 2022; 22(1):e130921196417. PubMed ID: 34517808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and the liver: What do we know after six months of the pandemic?
    Fierro NA
    Ann Hepatol; 2020; 19(6):590-591. PubMed ID: 32956871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.
    Cha MH; Regueiro M; Sandhu DS
    World J Gastroenterol; 2020 May; 26(19):2323-2332. PubMed ID: 32476796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
    Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
    Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, patterns, risk factors, and histopathological findings of liver injury in coronavirus disease 2019 (COVID-19): a scoping review.
    Bin Arif T; Khalid S; Siddiqui MS; Hussain H; Sohail H
    Hong Kong Med J; 2021 Jun; 27(1):198-209. PubMed ID: 33122448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of the COVID-19 associated liver injury.
    Wong YJ; Tan M; Zheng Q; Li JW; Kumar R; Fock KM; Teo EK; Ang TL
    Ann Hepatol; 2020; 19(6):627-634. PubMed ID: 32882393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
    Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
    Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.